OTLK 250117 12.50C (OTLK250117C12500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

OTLK250117C12500

Watchlist

0.05
0.000.00%

15min DelayClose Jan 3 16:00 ET

0.05High0.05Low

Intraday

5D
Daily

News

Express News | Outlook Therapeutics Inc : Guggenheim Cuts Target Price to $12 From $38
ReutersJan 3 06:28 ET
Outlook Therapeutics Stock Surges on Positive Outlook Despite Loss
Yahoo FinanceDec 30, 2024 07:45 ET
Outlook Therapeutics Faces Business Risks From Third-Party Manufacturing Dependencies
TipRanksDec 29, 2024 01:00 ET
Outlook Therapeutics Reports 2024 Financial Results
TipRanksDec 27, 2024 22:50 ET
Outlook Therapeutics | 10-K: FY2024 Annual Report
SECDec 27, 2024 16:34 ET · Announcements
Outlook Therapeutics Shares Up, Outlines Plans for Macular Degeneration Treatment
WSJDec 27, 2024 13:04 ET

Comments

carlton griffiths

Yesterday 02:12

$Outlook Therapeutics (OTLK.US)$ good news

carlton griffiths

Dec 30, 2024 17:41

Share Your Profit/Loss

Trytosaveabit

Dec 4, 2024 07:07

News

$Outlook Therapeutics (OTLK.US)$ Reuters
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025

Darrion

Dec 2, 2024 18:50

$Outlook Therapeutics (OTLK.US)$ $3 tonight. A retest at $2.4 yesterday.

DCCTrader

Dec 2, 2024 18:37

$Outlook Therapeutics (OTLK.US)$ 👀potential overnight play of today but I don’t like going long in red day